118 related articles for article (PubMed ID: 18598736)
41. The ABCB1-1Delta mutation is not responsible for subchronic neurotoxicity seen in dogs of non-collie breeds following macrocyclic lactone treatment for generalized demodicosis.
Bissonnette S; Paradis M; Daneau I; Silversides DW
Vet Dermatol; 2009 Feb; 20(1):60-6. PubMed ID: 19152588
[TBL] [Abstract][Full Text] [Related]
42. Involvement of the pyrilamine transporter, a putative organic cation transporter, in blood-brain barrier transport of oxycodone.
Okura T; Hattori A; Takano Y; Sato T; Hammarlund-Udenaes M; Terasaki T; Deguchi Y
Drug Metab Dispos; 2008 Oct; 36(10):2005-13. PubMed ID: 18606742
[TBL] [Abstract][Full Text] [Related]
43. Depleted uranium is not toxic to rat brain endothelial (RBE4) cells.
Dobson AW; Lack AK; Erikson KM; Aschner M
Biol Trace Elem Res; 2006 Apr; 110(1):61-72. PubMed ID: 16679548
[TBL] [Abstract][Full Text] [Related]
44. A polarized localization of amino acid/carnitine transporter B(0,+) (ATB(0,+)) in the blood-brain barrier.
Czeredys M; Mysiorek C; Kulikova N; Samluk Ł; Berezowski V; Cecchelli R; Nałecz KA
Biochem Biophys Res Commun; 2008 Nov; 376(2):267-70. PubMed ID: 18771654
[TBL] [Abstract][Full Text] [Related]
45. The first step into the brain: uptake of NIO-PBCA nanoparticles by endothelial cells in vitro and in vivo, and direct evidence for their blood-brain barrier permeation.
Weiss CK; Kohnle MV; Landfester K; Hauk T; Fischer D; Schmitz-Wienke J; Mailänder V
ChemMedChem; 2008 Sep; 3(9):1395-403. PubMed ID: 18613205
[TBL] [Abstract][Full Text] [Related]
46. Challenges for blood-brain barrier (BBB) screening.
Jeffrey P; Summerfield SG
Xenobiotica; 2007; 37(10-11):1135-51. PubMed ID: 17968740
[TBL] [Abstract][Full Text] [Related]
47. Association of a polymorphism in the ABCB1 gene with Parkinson's disease.
Westerlund M; Belin AC; Anvret A; Håkansson A; Nissbrandt H; Lind C; Sydow O; Olson L; Galter D
Parkinsonism Relat Disord; 2009 Jul; 15(6):422-4. PubMed ID: 19196542
[TBL] [Abstract][Full Text] [Related]
48. Effect of P-glycoprotein-mediated efflux on cerebrospinal fluid concentrations in rhesus monkeys.
Tang C; Kuo Y; Pudvah NT; Ellis JD; Michener MS; Egbertson M; Graham SL; Cook JJ; Hochman JH; Prueksaritanont T
Biochem Pharmacol; 2009 Sep; 78(6):642-7. PubMed ID: 19481060
[TBL] [Abstract][Full Text] [Related]
49. Several major antiepileptic drugs are substrates for human P-glycoprotein.
Luna-Tortós C; Fedrowitz M; Löscher W
Neuropharmacology; 2008 Dec; 55(8):1364-75. PubMed ID: 18824002
[TBL] [Abstract][Full Text] [Related]
50. Effect of baicalin and berberine on transport of nimodipine on primary-cultured, rat brain microvascular endothelial cells.
Zhang DM; Liu HY; Xie L; Liu XD
Acta Pharmacol Sin; 2007 Apr; 28(4):573-8. PubMed ID: 17376298
[TBL] [Abstract][Full Text] [Related]
51. Expression of Claudin-1, Claudin-3 and Claudin-5 in human blood-brain barrier mimicking cell line ECV304 is inducible by glioma-conditioned media.
Neuhaus W; Wirth M; Plattner VE; Germann B; Gabor F; Noe CR
Neurosci Lett; 2008 Dec; 446(2-3):59-64. PubMed ID: 18817843
[TBL] [Abstract][Full Text] [Related]
52. Species differences in blood-brain barrier transport of three positron emission tomography radioligands with emphasis on P-glycoprotein transport.
Syvänen S; Lindhe O; Palner M; Kornum BR; Rahman O; Långström B; Knudsen GM; Hammarlund-Udenaes M
Drug Metab Dispos; 2009 Mar; 37(3):635-43. PubMed ID: 19047468
[TBL] [Abstract][Full Text] [Related]
53. Increased transendothelial permeability of anti-cancer agent carboplatin with the aid of hyperbaric oxygenation.
Yamazaki H; Shimizu M; Murayama N; Tanaka K; Nion S; Cecchelli R
Xenobiotica; 2008 Oct; 38(10):1298-304. PubMed ID: 18798124
[TBL] [Abstract][Full Text] [Related]
54. Canine ABCB1 and macrocyclic lactones: heartworm prevention and pharmacogenetics.
Mealey KL
Vet Parasitol; 2008 Dec; 158(3):215-22. PubMed ID: 18922637
[TBL] [Abstract][Full Text] [Related]
55. P-glycoprotein efflux transporter activity often displays biphasic dose-response relationships.
Calabrese EJ
Crit Rev Toxicol; 2008; 38(5):473-87. PubMed ID: 18568867
[TBL] [Abstract][Full Text] [Related]
56. Expression and possible role of creatine transporter in the brain and at the blood-cerebrospinal fluid barrier as a transporting protein of guanidinoacetate, an endogenous convulsant.
Tachikawa M; Fujinawa J; Takahashi M; Kasai Y; Fukaya M; Sakai K; Yamazaki M; Tomi M; Watanabe M; Sakimura K; Terasaki T; Hosoya K
J Neurochem; 2008 Nov; 107(3):768-78. PubMed ID: 18761709
[TBL] [Abstract][Full Text] [Related]
57. Increased densities of monocarboxylate transport protein MCT1 after chronic administration of nicotine in rat brain.
Canis M; Mack B; Gires O; Maurer MH; Kuschinsky W; Duembgen L; Duelli R
Neurosci Res; 2009 Aug; 64(4):429-35. PubMed ID: 19433117
[TBL] [Abstract][Full Text] [Related]
58. Regional differences in capillary density, perfusion rate, and P-glycoprotein activity: a quantitative analysis of regional drug exposure in the brain.
Zhao R; Pollack GM
Biochem Pharmacol; 2009 Oct; 78(8):1052-9. PubMed ID: 19523457
[TBL] [Abstract][Full Text] [Related]
59. The effect of drug lipophilicity on P-glycoprotein-mediated colchicine efflux at the blood-brain barrier.
Khan EU; Reichel A; Begley DJ; Roffey SJ; Jezequel SG; Abbott NJ
Int J Clin Pharmacol Ther; 1998 Feb; 36(2):84-6. PubMed ID: 9520152
[No Abstract] [Full Text] [Related]
60. Interaction of tomato lectin with ABC transporter in cancer cells: glycosylation confers functional conformation of P-gp.
Molnár J; Kars MD; Gündüz U; Engi H; Schumacher U; Van Damme EJ; Peumans WJ; Makovitzky J; Gyémánt N; Molnár P
Acta Histochem; 2009; 111(4):329-33. PubMed ID: 19124148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
